Regulatory PathRegulatory requirements compared

Active substances

Betamethasone + Neomycin

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
BETAMED-N CREAM0.5,0.1 % (W/W),% (W/W)Cream · Topical1 TubeSAR 11.70Generic · PrescriptionMEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIESValid
BETNOVATE-N 0.1% CREAM0.5,0.1 %,%Cream · Topical1 TubeSAR 10.70Generic · PrescriptionGLAXO SAUDI ARABIAValid
BETNOVATE-N OINTMENT0.5,0.1 % (W/W),% (W/W)Ointment · Topical1 TubeSAR 10.70Generic · PrescriptionGLAXO SAUDI ARABIAValid
BETAMED-N OINTMENT0.5,0.1 % (W/W),% (W/W)Ointment · Topical1 TubeSAR 11.70Generic · PrescriptionMEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIESWithdrawn by regulatory authority · Not Marketed
BETAVAL-N CREAM0.1, 0.5 %Cream · Topical1 TubeSAR 2.95NCE · PrescriptionAPMWithdrawn by MAH · Not Marketed
BETAVAL-N CREAM0.1, 0.5 %Cream · Topical1 TubeSAR 4.30NCE · PrescriptionAPMWithdrawn by MAH · Not Marketed
BETAVAL-N OINT0.1, 0.5 %Ointment · Topical1 TubeSAR 4.30NCE · PrescriptionAPMWithdrawn by MAH · Not Marketed
BETAVAL-N OINT0.1, 0.5 %Ointment · Topical1 TubeSAR 2.95Generic · PrescriptionAPMWithdrawn by MAH · Not Marketed
BETONATE-N CREAM0.1, 0.5 %Cream · Topical1 TubeSAR 6.80Generic · PrescriptionSHAPHACO PHARMACEUTICALSuspended · Not Marketed
BETONATE-N OINTMENT0.1, 0.5 %Ointment · Topical1 TubeSAR 7.35Generic · PrescriptionSHAPHACO PHARMACEUTICALSuspended · Not Marketed
Indications — CHI Daman Drug Formulary

ECZEMA

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
NHS Drug TariffBetamethasone 0.1% / Neomycin 0.5% ear/eye/nose drops£2.3910 ml1 Oct 2026
NHS Drug TariffBetamethasone valerate 0.1% / Neomycin 0.5% cream£42.8630 gram1 Oct 2026
NHS Drug TariffBetamethasone valerate 0.1% / Neomycin 0.5% cream£133.22100 gram1 Oct 2026
NHS Drug TariffBetamethasone valerate 0.1% / Neomycin 0.5% ointment£42.8630 gram1 Oct 2026
NHS Drug TariffBetamethasone valerate 0.1% / Neomycin 0.5% ointment£133.22100 gram1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.